Biotech Values

[DewDiligence]

MNTA: You do still believe the stock price will be much higher from current levels even if the other generics [for Lovenox] are all approved though, correct?

I don’t know how the market would react to simultaneous FDA approval of all three Lovenox ANDA’s because such an outcome would contain both positive and negative aspects for MNTA. The positive is that any Lovenox approval provides near-term cash flow; the negative is that approval of the other ANDA’s would cause investors to downgrade the value of MNTA’s proprietary technology.